Showing results (51-60 of 138) with videos related to
Sort By:
Pageof 14
Metabolites|January 21, 2023
The Role of Advanced Glycation End Products on DyslipidemiaJelena Vekic, Sanja Vujcic, Biljana Bufan, et al.Journal of Clinical Medicine|May 27, 2026
Lipid Signatures Associated with Diabetic Peripheral Neuropathy in Obesity and Type 2 Diabetes-A Systematic ReviewCristina Mocanu Chitan, Teodor Salmen, Marius-Costin Chitu, et al.Pharmaceutics|April 23, 2022
Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDLJelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, et al.Experimental and Therapeutic Medicine|December 28, 2020
Gestational diabetes - modern management and therapeutic approach (Review)Camelia Sandu, Cristina Bica, Teodor Salmen, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 15, 2020
Gut microbiota and aging-A focus on centenariansAdriana Florinela Cӑtoi, Andreea Corina, Niki Katsiki, et al.International Journal of Molecular Sciences|April 30, 2021
Novel Therapeutical Approaches to Managing Atherosclerotic RiskRosaria Vincenza Giglio, Anca Pantea Stoian, Khalid Al-Rasadi, et al.Current Pharmaceutical Design|April 26, 2022
Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic ReviewAna Maria Dascalu, Manfredi Rizzo, Ali A Rizvi, et al.Healthcare (Basel, Switzerland)|April 3, 2021
Predictors of Burnout in Healthcare Workers during the COVID-19 PandemicAdriana Cotel, Florinda Golu, Anca Pantea Stoian, et al.Current Atherosclerosis Reports|August 4, 2021
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?Arrigo F G Cicero, Federica Fogacci, Anca Pantea Stoian, et al.Expert Opinion on Drug Safety|April 3, 2020
An overview of statin-induced myopathy and perspectives for the futureDragana Nikolic, Maciej Banach, Roberta Chianetta, et al.Pageof 14